RxDoctor Payments Data

Megan Huddleston, PA

Physician Assistant · Crossville, TNNPI 1073899746

Payments from drug & device makers

$8,477in general payments, 2019–2025

Across 541 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Bayer$641
  • Takeda Pharmaceuticals U.S.A., Inc.$630
  • GSK$605
  • Pfizer$524
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$8,477100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,477 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$85,478
Medicare patients
485
Services billed
1,623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban134$171,881
Xigduo XrDapaglifloz Propaned/Metformin62$70,426
XareltoRivaroxaban67$63,148
OzempicSemaglutide52$54,753
JardianceEmpagliflozin29$40,368
MounjaroTirzepatide34$36,681
JanuviaSitagliptin Phosphate24$29,279
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$26,490
FarxigaDapagliflozin Propanediol28$24,330
Synjardy XrEmpagliflozin/Metformin Hcl14$24,109
LinzessLinaclotide14$19,883
EntrestoSacubitril/Valsartan21$18,968
MyrbetriqMirabegron16$15,022
Atorvastatin Calcium539$7,248
Omeprazole380$6,594

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$524$171,881134 claims
Boehringer IngelheimJardiance, Synjardy Xr$38$64,47743 claims
Johnson & JohnsonXarelto$114$63,14867 claims
Novo NordiskOzempic$1,187$54,75352 claims
Lilly USA, LLCMounjaro$389$36,68134 claims
MerckJanuvia$189$29,27924 claims
GSKTrelegy Ellipta$605$26,49020 claims
AstraZenecaFarxiga$306$24,33028 claims
AbbVieLinzess, Synthroid$1,713$23,63971 claims
NovartisEntresto$72$18,96821 claims
Astellas Pharma US IncMyrbetriq$78$15,02216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Crossville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →